» Authors » Kazimierz Ciechanowski

Kazimierz Ciechanowski

Explore the profile of Kazimierz Ciechanowski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 196
Citations 818
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Marchelek-Mysliwiec M, Kosik-Bogacka D, Ciechanowski K, Marchelek E, Lanocha-Arendarczyk N, Grubman-Nowak M, et al.
Int Marit Health . 2025 Jan; 75(4):245-253. PMID: 39743878
There are many species of animals in the marine environment which are potentially dangerous to humans. Cnidarians that are responsible for burns are mainly found in tropical waters, but there...
2.
Turon-Skrzypinska A, Minko A, Ryl A, Cymbaluk-Ploska A, Domanski M, Ciechanowski K, et al.
BMC Nephrol . 2025 Jan; 26(1):1. PMID: 39743553
Background: The problem of reduced physical activity in patients with stage 5 Chronic Kidney Disease (CKD) is becoming more and more interesting in the medical community. One of the innovative...
3.
Debska-Slizien A, Kuzmiuk-Glembin I, Hozejowski R, Kaminska D, Krajewska M, Zawiasa-Bryszewska A, et al.
J Clin Med . 2024 Oct; 13(20). PMID: 39458191
: The tacrolimus concentration-to-dose (C/D) ratio is valuable for optimizing nephrotoxicity-related renal outcomes. Prospective data on the C/D ratio in kidney transplant recipients newly treated with MeltDose tacrolimus are limited....
4.
Bogacka A, Olszewska M, Ciechanowski K
Int J Mol Sci . 2024 Oct; 25(20). PMID: 39456817
The prevalence of chronic kidney disease (CKD) worldwide increases as the population ages. The progression of the disease increases the risk of complications and death and leads to end-stage renal...
5.
Malecki M, Okulewicz P, Lisak M, Safranow K, Domanski L, Ciechanowski K, et al.
J Clin Med . 2024 Apr; 13(8). PMID: 38673616
: Osteoprotegerin (OPG) is a member of the tumor necrosis factor receptor family involved in processes in many inflammatory states. OPG concentration is enhanced in the majority of chronic kidney...
6.
Turon-Skrzypinska A, Minko A, Ryl A, Mankowska K, Ciechanowski K, Bereda Z, et al.
J Clin Med . 2024 Apr; 13(8). PMID: 38673595
Chronic kidney disease is a significant public health issue associated with reduced physical activity. This can lead to mineral and bone disorders and increased levels of inflammatory markers. One innovative...
7.
Szumilewicz A, Davenport M, Scholz A, Sikora-Szubert A, Santos-Rocha R, Karowicz-Bilinska A, et al.
Ginekol Pol . 2024 Feb; PMID: 38334341
Introduction: Physical activity during pregnancy is established to derive clinically meaningful improvements in pregnancy, childbirth, and postpartum health outcomes. Evidence-based pre-screening tools have been developed to support the implementation of...
8.
Pietrzak-Nowacka M, Safranow K, Plonska-Gosciniak E, Nowacki A, Pozniak P, Gutowski P, et al.
Kidney Blood Press Res . 2023 Dec; 49(1):9-19. PMID: 38096797
Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease with a prevalence of 1:400 to 1:1,000 in Caucasians. It is caused by mutations in the...
9.
Turon-Skrzypinska A, Rotter I, Przybycinski J, Szylinska A, Minko A, Ciechanowski K, et al.
J Clin Med . 2023 Aug; 12(16). PMID: 37629400
Cytokines are a group of fine proteins which play a key role in the regulation of various biological processes, including inflammatory reactions. Proinflammatory cytokines, such as interleukin 1β (IL-1β), interleukin...
10.
Kwiatkowska E, Kajdy A, Sikora-Szubert A, Karowicz-Bilinska A, Zembron-Lacny A, Ciechanowski K, et al.
Ginekol Pol . 2023 Aug; PMID: 37599577
No abstract available.